Rosecliff Acquisition I : Business Combination Agreement - Form 8-K
April 11, 2023 Spectral MD Holdings, Ltd. ... | April 11, 2023
Source: marketscreener.com
📰 Diagnostics Platform News
Diagnostics Platform News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Diagnostics Platform. Real-time updates on events, politics, business and more.
Spectral MD Holdings, Ltd., an FDA Breakthrough Designated company focused on Artificial Intelligence driven Medical Diagnostic Solutions, to be Listed on Nasdaq Through Business Combination with Rosecliff Acquisition Corp I
Spectral MD is an Artificial Intelligence company focused on predictive medical diagnostics. The Company’s FDA Breakthrough Designated DeepView AI Wound Diagnostics platform uses proprietary... | April 11, 2023
United States City Of United Kingdom Mike Murphy Company Deepview Deepview Ai Wound Diagnostics Technology
Source: marketscreener.com
Rosecliff Acquisition Corp. I: Spectral MD Holdings, Ltd., an FDA Breakthrough Designated company focused on Artificial Intelligence driven Medical Diagnostic Solutions, to be Listed on Nasdaq Through Business Combination with Rosecliff Acquisition Corp I
Spectral MD is an Artificial Intelligence (AI) company focused on predictive medical diagnostics. The Company's FDA Breakthrough Designated DeepView AI Wound Diagnostics platform ("DeepView") uses
Source: finanznachrichten.de
RNA Disease Diagnostics Expands Board of Directors
- Lead Co-Inventor and Licensor of RNADD’s Molecular Diagnostics Platform to Help Guide its Commercialization - - Company’s President Expands Role - ...
Source: globenewswire.com
Harvard Wyss Institute's eRapid sensor technology licensed
The low-cost multiplexed electrochemical biomarker detection platform will be commercialized in point-of-care diagnostics to be put into the hands of...
Boston University United States University Of Massachusetts Medical School Massachusetts Institute Of Technology Harvard University Tufts University
Source: globenewswire.com
Wyss Institute Licenses eRapid Sensor Technology to Antisoma Therapeutics
Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Australian biotech company The iQ Group Global Ltd. announced that the Institute's electrochemical eRapid technology has been licensed to Antisoma Therapeutics Pty. Ltd., a subsidiary of The iQ Group Global.
Source: azosensors.com
Harvard Wyss Institute's eRapid sensor technology licensed to Antisoma Therapeutics to ... | Your Money
Wyss Institute for Biologically Inspired Engineering at Harvard University, March 07, 2022 (GLOBE NEWSWIRE) -- (BOSTON) — Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Australian
United States Boston University University Of Massachusetts Medical School Massachusetts Institute Of Technology Harvard University Tufts University
Source: kulr8.com
Cystic Fibrosis Modeled Using New Microfluidic Organ-on-a-Chip
Scientists have developed a microfluidic organ-on-a-chip preclinical model of the cystic fibrosis lung airway.
United States Roberto Plebani Ratnakar Potla Donald Ingber Annnunzio University Of Chieti Pescara Cystic Fibrosis Foundation
Source: technologynetworks.com
Human lung airway-on-a-chip faithfully recapitulates cystic fibrosis pathology
The inherited progressive disorder cystic fibrosis (CF) causes severe damage to the lungs, and other tissues in the body by affecting the cells that produce mucus, sweat, and digestive juices.
United States Roberto Plebani Donald Ingber Ratnakar Potla Emily Henderson Annnunzio University Of Chieti Pescara
Source: news-medical.net